ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

Clinical trial NCT01972035 · COMPLETED

Trial details

NCT number: NCT01972035
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transplantation Infection Epstein-Barr Virus Infections Cytomegalovirus Infections

Start date: 2014-08-01
Primary completion: 2021-02-28
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.